Antu Eapan Thomas

Stock Analyst at Geojit Research

(1.31)

# 3,570

Out of 4,476 analysts

44

Total ratings

51.3%

Success rate

-0.9%

Average return

Main Sectors:

Healthcare Financials Industrials

Top Industries:

Medical Care Facilities Engineering & Construction Insurance - Life Drug Manufacturers - Specialty & Generic Real Estate - Development

Stocks Rated by Antu Eapan Thomas

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NSE: MANKIND Mankind Pharma Limited	Maintained: Buy	₹2,660	$2,528.60	+5.20%	1	Jun 16, 2026
	NSE: FORTIS Fortis Healthcare Limited	Reiterated: Buy	₹1,150	$974.60	+18.00%	1	Jun 15, 2026
	NSE: PVRINOX PVR INOX Limited	Maintained: Buy	₹1,065 → ₹1,189	$1,001.25	+18.75%	2	Jun 5, 2026
	NSE: RAINBOW Rainbow Children's Medicare Limited	Initiated Coverage: Buy	₹1,679	$1,440.00	+16.60%	1	May 27, 2026
	NSE: SBICARD SBI Cards and Payment Services Limited	Maintained: Buy	₹950.00 → ₹698.00	$603.80	+15.60%	2	May 18, 2026
	NSE: LICI Life Insurance Corporation of India	Reiterated: Buy	₹544.00 → ₹467.00	$430.25	+8.54%	3	Mar 18, 2026
	NSE: NBCC NBCC (India) Limited	Rated: Hold	n/a	$102.36	-	1	Mar 17, 2026
	NSE: GODREJPROP Godrej Properties Limited	Maintained: Buy	₹2,096	$1,996.40	+4.99%	1	Feb 26, 2026
	NSE: AMBER Amber Enterprises India Limited	Initiated Coverage: Buy	₹9,156	$7,484.50	+22.33%	1	Feb 23, 2026
	NSE: HCG HealthCare Global Enterprises Limited	Upgraded: Buy	₹628.00 → ₹724.00	$655.95	+10.37%	2	Feb 19, 2026
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	₹780.00	$850.65	-8.31%	1	Feb 19, 2026
	XXXX XXXXXXXXXXXXXXXX Upgrade	Upgraded: Buy	₹1,180	$1,153.40	+2.31%	1	Feb 16, 2026
	XXXX XXXXXXXXXXXXXXXX Upgrade	Reiterated: Buy	₹568.00 → ₹791.00	$280.40	+182.10%	3	Feb 11, 2026
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	₹686.00	$562.50	+21.96%	1	Feb 10, 2026
	XXXX XXXXXXXXXXXXXXXX Upgrade	Reiterated: Buy	₹4,409 → ₹4,560	$4,026.60	+13.25%	2	Feb 1, 2026
	XXXX XXXXXXXXXXXXXXXX Upgrade	Reiterated: Buy	₹857.00 → ₹828.00	$567.70	+45.85%	4	Jan 29, 2026
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	₹2,244 → ₹2,080	$1,772.80	+17.33%	2	Jan 28, 2026
	XXXX XXXXXXXXXXXXXXXX Upgrade	Upgraded: Buy	₹312.00 → ₹439.00	$426.80	+2.86%	2	Jan 2, 2026
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgraded: Hold	₹1,076	$1,040.00	+3.46%	1	Jan 1, 2026
	XXXX XXXXXXXXXXXXXXXX Upgrade	Upgraded: Buy	₹1,085	$1,126.80	-3.71%	1	Nov 11, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	₹2,254	$1,790.00	+25.92%	1	Nov 10, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	₹1,790 → ₹1,613	$1,410.10	+14.39%	2	Nov 7, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	₹1,015	$900.10	+12.77%	1	Oct 31, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Upgraded: Buy	₹1,820	$1,442.90	+26.13%	1	Oct 31, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Reiterated: Buy	₹1,791 → ₹1,247	$571.80	+118.08%	2	Oct 8, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Reiterated: Buy	₹3,691	$2,093.50	+76.31%	1	Jul 15, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Buy	₹386.00	$236.00	n/a	1	Jun 9, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Hold	₹2,770	$785.00	n/a	1	Apr 2, 2025
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintained: Hold	₹326.00	$308.15	n/a	1	Dec 10, 2024

Mankind Pharma Limited

Jun 16, 2026

Maintained: Buy

Price Target: ₹2,660

Current: $2,528.60

Upside: +5.20%

Fortis Healthcare Limited

Jun 15, 2026

Reiterated: Buy

Price Target: ₹1,150

Current: $974.60

Upside: +18.00%

PVR INOX Limited

Jun 5, 2026

Maintained: Buy

Price Target: ₹1,065 → ₹1,189

Current: $1,001.25

Upside: +18.75%

Rainbow Children's Medicare Limited

May 27, 2026

Initiated Coverage: Buy

Price Target: ₹1,679

Current: $1,440.00

Upside: +16.60%

SBI Cards and Payment Services Limited

May 18, 2026

Maintained: Buy

Price Target: ₹950.00 → ₹698.00

Current: $603.80

Upside: +15.60%

Life Insurance Corporation of India

Mar 18, 2026

Reiterated: Buy

Price Target: ₹544.00 → ₹467.00

Current: $430.25

Upside: +8.54%

NBCC (India) Limited

Mar 17, 2026

Rated: Hold

Price Target: n/a

Current: $102.36

Upside: -

NSE: GODREJPROP

Godrej Properties Limited

Feb 26, 2026

Maintained: Buy

Price Target: ₹2,096

Current: $1,996.40

Upside: +4.99%

Amber Enterprises India Limited

Feb 23, 2026

Initiated Coverage: Buy

Price Target: ₹9,156

Current: $7,484.50

Upside: +22.33%

HealthCare Global Enterprises Limited

Feb 19, 2026

Upgraded: Buy

Price Target: ₹628.00 → ₹724.00

Current: $655.95

Upside: +10.37%

Feb 19, 2026

Maintained: Buy

Price Target: ₹780.00

Current: $850.65

Upside: -8.31%

Feb 16, 2026

Upgraded: Buy

Price Target: ₹1,180

Current: $1,153.40

Upside: +2.31%

Feb 11, 2026

Reiterated: Buy

Price Target: ₹568.00 → ₹791.00

Current: $280.40

Upside: +182.10%

Feb 10, 2026

Maintained: Buy

Price Target: ₹686.00

Current: $562.50

Upside: +21.96%

Feb 1, 2026

Reiterated: Buy

Price Target: ₹4,409 → ₹4,560

Current: $4,026.60

Upside: +13.25%

Jan 29, 2026

Reiterated: Buy

Price Target: ₹857.00 → ₹828.00

Current: $567.70

Upside: +45.85%

Jan 28, 2026

Maintained: Buy

Price Target: ₹2,244 → ₹2,080

Current: $1,772.80

Upside: +17.33%

Jan 2, 2026

Upgraded: Buy

Price Target: ₹312.00 → ₹439.00

Current: $426.80

Upside: +2.86%

Jan 1, 2026

Downgraded: Hold

Price Target: ₹1,076

Current: $1,040.00

Upside: +3.46%

Nov 11, 2025

Upgraded: Buy

Price Target: ₹1,085

Current: $1,126.80

Upside: -3.71%

Nov 10, 2025

Maintained: Buy

Price Target: ₹2,254

Current: $1,790.00

Upside: +25.92%

Nov 7, 2025

Maintained: Buy

Price Target: ₹1,790 → ₹1,613

Current: $1,410.10

Upside: +14.39%

Oct 31, 2025

Maintained: Buy

Price Target: ₹1,015

Current: $900.10

Upside: +12.77%

Oct 31, 2025

Upgraded: Buy

Price Target: ₹1,820

Current: $1,442.90

Upside: +26.13%

Oct 8, 2025

Reiterated: Buy

Price Target: ₹1,791 → ₹1,247

Current: $571.80

Upside: +118.08%

Jul 15, 2025

Reiterated: Buy

Price Target: ₹3,691

Current: $2,093.50

Upside: +76.31%

Jun 9, 2025

Maintained: Buy

Price Target: ₹386.00

Current: $236.00

Upside: n/a

Apr 2, 2025

Maintained: Hold

Price Target: ₹2,770

Current: $785.00

Upside: n/a

Dec 10, 2024

Maintained: Hold

Price Target: ₹326.00

Current: $308.15

Upside: n/a